Asahi Life Asset Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.1M | Sell |
4,363
-86
| -2% | -$18.5K | 0.62% | 37 |
|
|
2026
Q1 | $968K | Sell |
4,449
-235
| -5% | -$52.1K | 0.63% | 37 |
|
|
2025
Q4 | $1.07M | Sell |
4,684
-463
| -9% | -$105K | 0.6% | 34 |
|
|
2025
Q3 | $1.19M | Buy |
5,147
+352
| +7% | +$71.7K | 0.66% | 34 |
|
|
2025
Q2 | $890K | Buy |
4,795
+2,975
| +163% | +$553K | 0.52% | 41 |
|
|
2025
Q1 | $381K | Sell |
1,820
-3,470
| -66% | -$675K | 0.25% | 103 |
|
|
2024
Q4 | $940K | Buy |
5,290
+1,090
| +26% | +$200K | 0.57% | 35 |
|
|
2024
Q3 | $829K | Sell |
4,200
-1,250
| -23% | -$233K | 0.5% | 39 |
|
|
2024
Q2 | $935K | Buy |
5,450
+3,450
| +173% | +$571K | 0.64% | 33 |
|
|
2024
Q1 | $364K | Sell |
2,000
-3,865
| -66% | -$666K | 0.22% | 112 |
|
|
2023
Q4 | $909K | Buy |
5,865
+3,790
| +183% | +$553K | 0.49% | 36 |
|
|
2023
Q3 | $309K | Sell |
2,075
-1,905
| -48% | -$280K | 0.11% | 116 |
|
|
2023
Q2 | $536K | Sell |
3,980
-2,020
| -34% | -$296K | 0.18% | 62 |
|
|
2023
Q1 | $956K | Sell |
6,000
-125
| -2% | -$19.1K | 0.3% | 49 |
|
|
2022
Q4 | $990K | Sell |
6,125
-270
| -4% | -$41.4K | 0.33% | 47 |
|
|
2022
Q3 | $858K | Buy |
6,395
+55
| +0.9% | +$7.89K | 0.27% | 44 |
|
|
2022
Q2 | $971K | Sell |
6,340
-790
| -11% | -$121K | 0.26% | 46 |
|
|
2022
Q1 | $1.16M | Sell |
7,130
-720
| -9% | -$105K | 0.16% | 46 |
|
|
2021
Q4 | $1.06M | Sell |
7,850
-60
| -0.8% | -$7.09K | 0.13% | 46 |
|
|
2021
Q3 | $853K | Sell |
7,910
-70
| -0.9% | -$8K | 0.12% | 51 |
|
|
2021
Q2 | $899K | Sell |
7,980
-550
| -6% | -$61.9K | 0.12% | 46 |
|
|
2021
Q1 | $923K | Buy |
8,530
+5,770
| +209% | +$617K | 0.13% | 47 |
|
|
2020
Q4 | $296K | Sell |
2,760
-1,790
| -39% | -$172K | 0.04% | 182 |
|
|
2020
Q3 | $399K | Sell |
4,550
-310
| -6% | -$29.2K | 0.06% | 101 |
|
|
2020
Q2 | $477K | Buy |
4,860
+3,170
| +188% | +$279K | 0.08% | 68 |
|
|
2020
Q1 | $129K | Sell |
1,690
-7,790
| -82% | -$664K | 0.02% | 179 |
|
|
2019
Q4 | $839K | Sell |
9,480
-730
| -7% | -$60.6K | 0.12% | 47 |
|
|
2019
Q3 | $773K | Buy |
10,210
+1,410
| +16% | +$96.7K | 0.13% | 48 |
|
|
2019
Q2 | $640K | Buy |
8,800
+6,240
| +244% | +$490K | 0.13% | 59 |
|
|
2019
Q1 | $206K | Sell |
2,560
-8,670
| -77% | -$709K | 0.03% | 165 |
|
|
2018
Q4 | $1.03M | Buy |
+11,230
| New | +$988K | 0.16% | 42 |
|
Other funds holding ABBV
Asahi Life Asset Management's ABBV Position: Q2 2026 in Review
Asahi Life Asset Management reduced its AbbVie (ABBV) stake by 1.9% in Q2 2026, selling an estimated $18.5K and leaving 4,363 shares worth $1.1M. The position accounts for 0.62% of the portfolio, ranked #37.
Asahi Life Asset Management first reported a position in ABBV in Q4 2018 and has held it in 31 quarters since. The position peaked at $1.19M in Q3 2025. 4,234 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Asahi Life Asset Management held 4,363 shares of AbbVie worth $1.1M as of Q2 2026.
- Asahi Life Asset Management sold 86 AbbVie shares in Q2 2026, an estimated $18.5K.
- AbbVie made up 0.62% of Asahi Life Asset Management's portfolio in Q2 2026, its #37 holding.
- Asahi Life Asset Management first reported a position in AbbVie in Q4 2018 and has held it in 31 quarters since.
- Asahi Life Asset Management's AbbVie position peaked at $1.19M in Q3 2025.
- 4,234 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Asahi Life Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.